The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
暂无分享,去创建一个
A. Hagemeijer | F. Mandelli | R. Willemze | G. Meloni | W. Fibbe | R. Zittoun | S. Suciu | G. Fillet | S. Keating | S. Amadori | T. Witte | P. Fazi | G. Solbu | B. Varet | E. Gallo | A. Belhabri